Medicus Sciences Acquisition Says Discussions Between Co, Anteris Regarding Possible Transactions Have Ceased
$MSAC
Blank Checks
Finance
-SEC Filing
-SEC Filing
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
15-12G - Medicus Sciences Acquisition Corp. (0001836517) (Filer)
25-NSE - Medicus Sciences Acquisition Corp. (0001836517) (Subject)
8-K - Medicus Sciences Acquisition Corp. (0001836517) (Filer)
NEW YORK, Feb. 13, 2023 /PRNewswire/ -- Medicus Sciences Acquisition Corp. (the "Company") (NASDAQ:MSAC), announced today that due to its inability to consummate an initial business combination within the time period required by its amended and restated memorandum and articles of association (the "Charter"), the Board of Directors of the Company has elected to dissolve and liquidate the Company in accordance with the provisions of its Charter, and will redeem all of the outstanding Class A ordinary shares that were included in the units issued in its initial public offering (the "Public Shares"), at a per-share redemption price of approximately $10.18. As of the close of business on Februar
SC 13G/A - Medicus Sciences Acquisition Corp. (0001836517) (Subject)
SC 13G/A - Medicus Sciences Acquisition Corp. (0001836517) (Subject)
SC 13G/A - Medicus Sciences Acquisition Corp. (0001836517) (Subject)